SMMT
Summit Therapeutics Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.2% ·
aandelenstroom +14.3% ·
netto nieuwe posities -13.3%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 125.39K | $2.14M | +1 | n/a |
| Q2 2026 | 86 | +5 | 84.30M | $1.23B | +8 | −2 |
| Q1 2026 | 82 | +1 | 68.40M | $1.29B | +10 | −10 |
| Q4 2025 | 81 | 0 | 72.69M | $1.27B | +1 | n/a |
| Q3 2025 | 15 | -1 | 45.07M | $931.26M | +1 | −3 |
| Q2 2025 | 14 | 0 | 38.14M | $811.62M | +1 | −1 |
| Q1 2025 | 11 | +1 | 18.29M | $352.78M | +1 | n/a |
| Q4 2024 | 10 | +1 | 17.85M | $318.58M | +1 | n/a |
| Q3 2024 | 8 | 0 | 10.94M | $239.67M | +1 | −1 |
| Q2 2024 | 8 | n/a | 7.47M | $58.27M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 11.38M | +31.2% | $235.11M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 2 | Fidelity (FMR) ✦ | 8.92M | -3.3% | $184.24M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 3 | BlackRock ✦ (passief) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ ×12 |
| 4 | State Street Global Advisors ✦ (passief) | 6.36M | +58.4% | $131.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 4.54M | +16.2% | $93.77M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passief) | 3.13M | +6.7% | $64.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 1.93M | n/a | $39.81M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 497.55K | n/a | $10.28M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 273.25K | n/a | $5.65M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 10 | Citadel Advisors ✦ | 202.71K | +97.9% | $4.19M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 187.48K | +740.3% | $3.87M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 12 | D. E. Shaw & Co. ✦ | 130.63K | -5.0% | $2.70M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 120.51K | -78.3% | $2.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 25.03K | Nieuw | $517,120 | 0.0% | New | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 15.73K | 0.0% | $324,920 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Two Sigma Investments | $517,120 | 0.0% |
Verlaten
| Norges Bank | $29.58M | was 0.0% |
| Marshall Wace | $5.78M | was 0.0% |
| Wellington Management | $844,689 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 223 houders, 118.88M aandelen, $2.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.